Diana Sabagh Sabagh
Child & Adolescent Psychiatry · Cleveland, OHNPI 1679891204
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 26.9% of the total. Reporting peaked in 2021 at $922 and has fallen 97.4% since, to $24 in 2024.
Across 89 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$405
- Takeda Pharmaceuticals U.S.A., Inc.$187
- Jazz Pharmaceuticals Inc.$176
- Otsuka America Pharmaceutical, Inc.$148
- Adlon Therapeutics L.p.$140
- Alkermes, Inc.$82
- plus $364 from 13 others
What the payments were for
- Food & beverage$1,501100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $405 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $187 |
| Jazz Pharmaceuticals Inc. | 4 | $176 |
| Otsuka America Pharmaceutical, Inc. | 8 | $148 |
| Adlon Therapeutics L.p. | 11 | $140 |
| Alkermes, Inc. | 4 | $82 |
| Merck | 4 | $62 |
| Sunovion Pharmaceuticals Inc. | 7 | $56 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $45 |
| Eisai Inc. | 2 | $34 |
| Corium, LLC | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| Tris Pharma Inc | 1 | $24 |
| Neos Therapeutics, LP | 1 | $21 |
| Bausch Health US, LLC | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$127
How this compares
$1,501 in reported general payments places this provider in the 80th percentile of 160 child & adolescent psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 11 | $547 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Cleveland
- Robert FindlingCleveland$125K
- Andre ProchoroffCleveland$26K
- Nora McNamaraCleveland$3K
- Samareh MoussavandCleveland$3K
- Dean ShandyCleveland$2K
- Rajalla PrewittCleveland$2K
- Mackenzie VarkulaCleveland$709
- Pilar LachhwaniCleveland$563
- Rick BowersMoraine$182K
- Joseph RiemanFremont$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.